Home

arbusto Contrapartida Movilizar aml mouse model Económico Apretar Aviación

Understanding cancer in mice and men | RIKEN
Understanding cancer in mice and men | RIKEN

Correction: A novel approach for relapsed/refractory FLT3mut+acute myeloid  leukaemia: synergistic effect of the combination of bispecific  FLT3scFv/NKG2D-CAR T cells and gilteritinib | Molecular Cancer | Full Text
Correction: A novel approach for relapsed/refractory FLT3mut+acute myeloid leukaemia: synergistic effect of the combination of bispecific FLT3scFv/NKG2D-CAR T cells and gilteritinib | Molecular Cancer | Full Text

A Mesenchymal Cell Niche in Skin for Acute Myeloid Leukemia | bioRxiv
A Mesenchymal Cell Niche in Skin for Acute Myeloid Leukemia | bioRxiv

Cancers | Free Full-Text | DJ4 Targets the Rho-Associated Protein Kinase  Pathway and Attenuates Disease Progression in Preclinical Murine Models of Acute  Myeloid Leukemia
Cancers | Free Full-Text | DJ4 Targets the Rho-Associated Protein Kinase Pathway and Attenuates Disease Progression in Preclinical Murine Models of Acute Myeloid Leukemia

CD123 is an excellent target in primary AML in vivo. (A) Primary AML... |  Download Scientific Diagram
CD123 is an excellent target in primary AML in vivo. (A) Primary AML... | Download Scientific Diagram

Near-infrared oxidative phosphorylation inhibitor integrates acute myeloid  leukemia–targeted imaging and therapy | Science Advances
Near-infrared oxidative phosphorylation inhibitor integrates acute myeloid leukemia–targeted imaging and therapy | Science Advances

Sox13 and M2-like leukemia-associated macrophages contribute to endogenous  IL-34 caused accelerated progression of acute myeloid leukemia | Cell Death  & Disease
Sox13 and M2-like leukemia-associated macrophages contribute to endogenous IL-34 caused accelerated progression of acute myeloid leukemia | Cell Death & Disease

Syngeneic leukemia models using lentiviral transgenics | Cell Death &  Disease
Syngeneic leukemia models using lentiviral transgenics | Cell Death & Disease

Frontiers | Overview of the Use of Murine Models in Leukemia and Lymphoma  Research
Frontiers | Overview of the Use of Murine Models in Leukemia and Lymphoma Research

Curcumin sensitizes response to cytarabine in acute myeloid leukemia by  regulating intestinal microbiota | Cancer Chemotherapy and Pharmacology
Curcumin sensitizes response to cytarabine in acute myeloid leukemia by regulating intestinal microbiota | Cancer Chemotherapy and Pharmacology

Mouse models of NPM1-mutated acute myeloid leukemia: biological and  clinical implications | Leukemia
Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications | Leukemia

Anti-leukemia effects of Ara-C@HFn and free Ara-C in AML mouse models.... |  Download Scientific Diagram
Anti-leukemia effects of Ara-C@HFn and free Ara-C in AML mouse models.... | Download Scientific Diagram

An Improved Protocol for Establishment of AML Patient-Derived Xenograft  Models - ScienceDirect
An Improved Protocol for Establishment of AML Patient-Derived Xenograft Models - ScienceDirect

Frontiers | Macrophages in Acute Myeloid Leukaemia: Significant Players in  Therapy Resistance and Patient Outcomes
Frontiers | Macrophages in Acute Myeloid Leukaemia: Significant Players in Therapy Resistance and Patient Outcomes

Iron metabolism in the MLL-AF9 AML mouse model. (A) MLL-AF9 + AML... |  Download Scientific Diagram
Iron metabolism in the MLL-AF9 AML mouse model. (A) MLL-AF9 + AML... | Download Scientific Diagram

The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid  leukemia cells by disrupting multiple tumor-addicted programs |  Haematologica
The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs | Haematologica

Animal models of acute lymphoblastic leukemia: Recapitulating the human  disease to evaluate drug efficacy and discover therapeutic targets -  ScienceDirect
Animal models of acute lymphoblastic leukemia: Recapitulating the human disease to evaluate drug efficacy and discover therapeutic targets - ScienceDirect

An improved pre-clinical patient-derived liquid xenograft mouse model for acute  myeloid leukemia | Journal of Hematology & Oncology | Full Text
An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemia | Journal of Hematology & Oncology | Full Text

Modelling acute myeloid leukemia (AML): What's new? A transition from the  classical to the modern | Drug Delivery and Translational Research
Modelling acute myeloid leukemia (AML): What's new? A transition from the classical to the modern | Drug Delivery and Translational Research

An improved pre-clinical patient-derived liquid xenograft mouse model for acute  myeloid leukemia | Journal of Hematology & Oncology | Full Text
An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemia | Journal of Hematology & Oncology | Full Text

A new marching order for the T cell army in the attack of AML
A new marching order for the T cell army in the attack of AML

JCI - mTORC1 is essential for leukemia propagation but not stem cell  self-renewal
JCI - mTORC1 is essential for leukemia propagation but not stem cell self-renewal

Mouse models of NPM1-mutated acute myeloid leukemia: biological and  clinical implications | Leukemia
Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications | Leukemia

a Schematic representation of the AML post MDS mouse model. The... |  Download Scientific Diagram
a Schematic representation of the AML post MDS mouse model. The... | Download Scientific Diagram

DAP suppressed tumor growth in an AML mouse model. U937 cells were... |  Download Scientific Diagram
DAP suppressed tumor growth in an AML mouse model. U937 cells were... | Download Scientific Diagram

Dissecting the early steps of MLL induced leukaemogenic transformation  using a mouse model of AML | Nature Communications
Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AML | Nature Communications

Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute  myeloid leukemia | Science
Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia | Science